1. OC-031 Outreach community testing for hepatitis C in an ethnic population. (23rd September 2015) Authors: Jafferbhoy, H; Miller, M; McIntyre, P; Mcleod, S; Dillon, J F Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P08 Spontaneous bacterial peritonitis prophylaxis: reducing the incidence of c difficile infection. (6th September 2011) Authors: Jafferbhoy, H; Miller, M H; Shekar, C; Lockhart, M; Dillon, J F Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P399 Vedolizumab therapy results in reduced hospitalisation and steroid use over 1-year: Results from the Scottish vedolizumab consortium. (16th January 2018) Authors: Plevris, N; Chuah, C S; Allen, R; Baker, P; Brennan, P; Churchhouse, A; Donoghue, E; Gaya, D; Jafferbhoy, H; Jenkinson, P; Jones, G; Macdonald, J; MacMaster, M; Mowat, C; Naismith, G; Potts, L; Saffouri, E; Seenan, J P; Sengupta, A; Shasi, P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P83 Intravenous drug use: not a barrier to achieving a sustained virological. (16th November 2010) Authors: Dillon, J; Jafferbhoy, H; Miller, M; Tait, J; Cleary, S Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PWE-045 Vedolizumab results in reduced hospitalisation and steroid use over 1-year:results from the scottish vedolizumab cohort. (8th June 2018) Authors: Plevris, Nikolas; Chuah, Cher; Jenkinson, Phil; Allen, R; Baker, P; Brennan, Paul; Churchhouse, Antonia; Din, S; Donoghue, Emma; Gaya, Daniel; Groome, Max; Jafferbhoy, H; Jones, G; Macdonald, Jonathan; MacMaster, Morag; Mowat, Craig; Naismith, G; Noble, C; Potts, L; Saffouri, E Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PWE-048 Performance of simple algorithm tests for the detection of fibrosis in non-alcoholic fatty liver disease. (23rd September 2015) Authors: Miller, M; Jafferbhoy, H; Walsh, S; Dillon, J Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PWE-049 Shotgun proteomics in the discovery of biomarkers of non-alcoholic fatty liver disease: an improved methodology. (23rd September 2015) Authors: Miller, M; Jafferbhoy, H; Ferguson, M A J; Dillon, J Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SP5.1.7 What did we miss? A 5 - year retrospective cohort study calculating the endoscopy miss rate for UGI cancers in a Scottish district general hospital. (28th October 2021) Authors: Rashid, M; Clyde, D; Driscoll, P J; Jafferbhoy, H Journal: British journal of surgery Issue: Volume 108:Supplement 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗